Posted on:
Our researchers at the Kolling Institute are working to improve the use of medications for dementia with a comprehensive analysis highlighting several concerning trends. The latest data indicates more than 420,000 people are living with dementia in Australia, including more women than men. The condition is the second leading cause of death in Australia. Leading
Posted on:
Two of the Kolling Institute’s emerging leaders are gaining attention after receiving the ATA Scientific Encouragement Award. The award, which was launched more than a decade ago, aims to provide young scientists with financial assistance to further their education and attend scientific meetings and conferences. Scientific officer Kevin Winardi from the Kolling’s Lab of Ageing
Posted on:
Generous community support is strengthening our research into oesophageal cancer, lifting hopes of improved treatments for the aggressive and deadly cancer. The Fight for a Cure charity has donated $100,000 towards Dr Colby Stevenson’s research, on top of a $100,000 donation from the Howlett family, in memory of their son Scott who died from the
Category:
Posted on:
Researchers at the Kolling Institute have welcomed the launch of Australia’s premier cancer clinical trials centre on the Royal North Shore Hospital campus. NORTH Sydney Trials and Research Van Norton Poche or NORTH STAR VNP has been made possible by a $20 million gift from the late Kay Van Norton Poche and her husband Greg.
Category:
Posted on:
Our researchers at the Kolling Institute are at the forefront of Meniere’s disease science developing the first humanised model of the disease ahead of gene therapy. The specialised team is led by world-leading Meniere’s disease researcher and neuroscientist Professor Jose Antonio Lopez-Escamez who relocated from Spain to the institute to pursue his ground-breaking work. His
Posted on:
We may soon have a convenient and painless approach to diagnose chronic kidney disease following research by the team from the Kolling Institute’s Renal Research Laboratory. Chronic kidney disease is an emerging global health issue, currently affecting more than 11 per cent of Australians and 13 per cent of the worldwide population. By 2032, it’s
Posted on:
Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute. Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders. Our teams have continued to increase their research impact, while forging significant new collaborations. They
Posted on:
Our ground-breaking leukaemia research at the Kolling Institute has received an important boost with the Cancer Council NSW announcing a $450,000 grant for Associate Professor Jenny Wang and her research team. The funds will help the development of a new therapy to greatly improve survival rates for those with acute myeloid leukaemia. This form of
Category:
Posted on:
A team of researchers from the Kolling Institute’s John Walsh Centre for Rehabilitation Research has launched a study to develop the first internationally accepted guidelines for assessing cognitive function after a spinal cord injury. The latest data indicates that over 15 million people globally live with a spinal cord injury, and in Australia, there are
Posted on:
A culture of collaboration is a key part of the Kolling Institute’s research impact, and just one example of this is a joint project to reduce the devastating impact of vascular disease linked to diabetes. The study has brought together research experts from endocrinology and cardiology to curb the number of lower limb amputations due
Category: